VHOSPITAL.CLINIC · Medical Condition
Scleroderma is a chronic autoimmune disease causing skin hardening, fibrosis of internal organs (lungs, kidneys, GI tract), and vascular abnormalities. Raynaud's phenomenon is often an early manifestation; there is no cure.
Early Signs of Scleroderma (Systemic Sclerosis)
Identify the earliest warning signs and symptoms of scleroderma (systemic sclerosis) before the condition becomes serious.
How to Manage Scleroderma (Systemic Sclerosis)
Evidence-based strategies and lifestyle changes to effectively manage scleroderma (systemic sclerosis) and reduce complications.
Clinical Overview
High-level clinical summary, typical presentation and rule-out logic for Scleroderma (Systemic Sclerosis)
Treatment & Management
Evidence-based treatment pathway, medications, monitoring & escalation for Scleroderma (Systemic Sclerosis)
Complications & Risks
Early, long-term, and emergency complications of Scleroderma (Systemic Sclerosis)
Prognosis & Outlook
Long-term clinical outlook, improving/worsening factors, and monitoring for Scleroderma (Systemic Sclerosis)
Differential Diagnosis
Conditions that mimic Scleroderma (Systemic Sclerosis) — key distinguishing features & tests
Scleroderma (Systemic Sclerosis) is frequently confused with these conditions — see head-to-head comparisons for distinguishing tests and treatment differences.
Content on this page is informed by evidence-based clinical sources including:
Describe your symptoms and get a structured clinical assessment — possible causes, red flags, and recommended next steps.
Start Free AI Analysis →